People with asthma know how important inhalers are, but they are also a source of planet-warming pollution. A new study looks at that impact and what can be done. Millions of people depend on ...

Pharmaceutical manufacturer GlaxoSmithKline (GSK) announced that as of Jan. 1 it would no longer produce the asthma inhaler Flovent, one of the most popular preventive and maintenance treatments ...

A new inhaler that treats chronic obstructive pulmonary disease (COPD) and also helps reduce environmental harm has been approved for use in the UK. This inhaler is already available in India ...

Most people with asthma and other lung diseases have no idea that commonly prescribed inhalers are helping make the planet warmer. Each puff has about the same climate impact as driving a gas ...

Sen. Bernie Sanders and President Biden joined forces Wednesday at the White House, championing the progress they've made on lowering the cost of inhalers and other expenses for Americans with asthma.

Starting Saturday, the cost of inhalers will fall for many Americans, as new out-of-pocket price caps go into effect for the asthma medications from AstraZeneca and Boehringer Ingelheim.

U.S. regulators approved dozens of inhalers to treat asthma and chronic obstructive pulmonary disease over a recent 15-year period, but a new study found that generic companies have only twice ...

Inhalers cause nearly half of GSK's global emissions. Its new design, which is about to enter Phase 3 trials, will slash the inhaler's emissions by 90%.

For the 25 million Americans with asthma, inhalers can be a lifeline. But those puffs can hurt the planet. "About three quarters of all inhalers used in the in this country are propellant-type ...

O KLAHOMA CITY — A 2019 bill signed by Governor Stitt authorized schools to stock emergency asthma inhalers in schools as a precaution for students. Last year, lawmakers secured new funding to ...

The bill also comes after several major manufacturers of inhalers pledged earlier this year to cap out-of-pocket costs for inhalers at $35 a month, starting in June and early next year.

But many of them are confused by one type in particular: asthma inhalers. According to the American College of Allergy, Asthma, and Immunology, approximately one in 12 Americans has asthma.